Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL25329375

O=C(OCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)c1cccnc1.O=C([O-])C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.50
KMT2A Q03164 5/20 0.50
TDP1 Q9NUW8 3/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
MAPK1 P28482 1/20 0.44
GAA P10253 2/20 0.43
PLOD2 O00469 1/20 0.42
PLOD3 O60568 1/20 0.42
PLOD1 Q02809 1/20 0.42
KDM4E B2RXH2 2/20 0.42
PKM P14618 1/20 0.42
ALDH1A1 P00352 4/20 0.42
USP2 O75604 2/20 0.41
MAPT P10636 4/20 0.41
POLB P06746 1/20 0.41
MEN1 O00255 2/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL31110582 1.00 LMNA (0.50) LMNAKMT2ATDP1L3MBTL1MAPK1
Hydrochloric Acid SCHEMBL31110604 0.83 L3MBTL1 (0.63) LMNAKMT2ATDP1L3MBTL1MAPK1
SCHEMBL31110610 0.83 L3MBTL1 (0.63) LMNAKMT2ATDP1L3MBTL1MAPK1
Hydrochloric Acid SCHEMBL25329121 0.83 L3MBTL1 (0.63) LMNAKMT2ATDP1L3MBTL1MAPK1
SCHEMBL31110588 0.81 LMNA (0.64) LMNAKMT2ATDP1L3MBTL1MAPK1
SCHEMBL31110564 0.79 L3MBTL1 (0.54) LMNAKMT2ATDP1L3MBTL1MAPK1
SCHEMBL31110569 0.78 LMNA (0.62) LMNAKMT2ATDP1L3MBTL1MAPK1
SCHEMBL31110603 0.77 LMNA (0.56) LMNAKMT2ATDP1L3MBTL1MAPK1
SCHEMBL31110599 0.77 LMNA (0.56) LMNAKMT2ATDP1L3MBTL1MAPK1
SCHEMBL31110609 0.77 LMNA (0.56) LMNAKMT2ATDP1L3MBTL1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4472948-A2 NICOTINATE AND NICOTINAMIDE RIBOSIDE-BASED COMPOUNDS AND DERIVATIVES THEREOF New Frontier Bio, Inc. (US) 2024-12-11 EP disclosed
WO-2023147161-A2 NICOTINATE AND NICOTINAMIDE RIBOSIDE-BASED COMPOUNDS AND DERIVATIVES THEREOF New Frontier Bio, Inc. (US) 2023-08-03 WO disclosed
US-20230242558-A1 NICOTINATE AND NICOTINAMIDE RIBOSIDE-BASED COMPOUNDS AND DERIVATIVES THEREOF New Frontier Bio, Inc. 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242558-A1 NICOTINATE AND NICOTINAMIDE RIBOSIDE-BASED COMPOUNDS AND DERIVATIVES THEREOF NAMPT, NNT, NAPRT LMNA 539/4885KMT2A 1449/4885TDP1 1721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.